The Effects of Stanford Accelerated Intelligent Neuromodulation Therapy on Explicit and Implicit Suicidal Cognition
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Depressive Disorder, Major
- Suicide
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Patients will receive either active or sham stimulation to the DLPFC. Patients will be randomized to either condition with a 50:50 chance.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
We recently developed a form of neuromodulation termed Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). SAINT-induced remission is associated with significant reductions in the functional connectivity of the neural network underlying explicit suicidal cognition (between sgACC-DMN). ...
We recently developed a form of neuromodulation termed Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). SAINT-induced remission is associated with significant reductions in the functional connectivity of the neural network underlying explicit suicidal cognition (between sgACC-DMN). This project aims to further elucidate the SAINT induced neural network changes underlying explicit suicidal cognition.
Tracking Information
- NCT #
- NCT03693105
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Nolan Williams, MD Stanford University
Get Well Soon